BioCentury | Jan 12, 2015
Emerging Company Profile

Neutralizing RNAi

...Diego Corporate partners: None Number of employees: 20 Funds raised: $18 million Investors: venBio LLC, Aeris Capital...
BioCentury | Dec 8, 2014
Financial News

Curetis financial update

...$34.3 million). New investors Qiagen and LSP Health Econimics Fund joined existing investors HBM Partners; Aeris Capital...
BioCentury | Sep 13, 2014
Financial News

Affimed raises $56M in IPO

...million ($15.4 million) from existing investors in a series E round last week. Investors included Aeris Capital...
BioCentury | Sep 3, 2014
Financial News

Affimed sets IPO terms, raises series E

...Capital; and Trout Capital are underwriters. The E round came from Affimed's existing investors, including Aeris Capital...
BioCentury | Jun 16, 2014
Finance

Legal tracks

...and a director of RNAi company Solstice Biologics LLC . Solstice's investors include venBio and Aeris Capital. ...
BioCentury | Oct 7, 2013
Finance

Deciphering GenomeDx

...Fund (GHIF) and another new investor that was not disclosed. Existing investors Baird Venture Partners, Aeris Capital...
BioCentury | Oct 7, 2013
Financial News

GenomeDx Biosciences completes venture financing

...Type: Venture financing Raised: Not disclosed Investors: Merck Global Health Innovation Fund; Baird Venture Partners; Aeris Capital...
BioCentury | Oct 1, 2013
Financial News

GenomeDx closes series B round

...Merck Global Health Innovation Fund and a new undisclosed investor. Existing investors Baird Venture Partners; Aeris Capital...
BioCentury | Jul 22, 2013
Company News

Affimed board of directors update

...Adi Hoess, CEO of Affimed, as a director of Amphivena; and Frank Muehlenbeck, partner at Aeris Capital...
BioCentury | Jul 22, 2013
Financial News

Affimed completes venture financing

...Cancer, Inflammation, Antibodies Date completed: 7/15/13 Type: Venture financing Raised: $14 million Investors: MPM Capital; Aeris Capital...
Items per page:
1 - 10 of 37
BioCentury | Jan 12, 2015
Emerging Company Profile

Neutralizing RNAi

...Diego Corporate partners: None Number of employees: 20 Funds raised: $18 million Investors: venBio LLC, Aeris Capital...
BioCentury | Dec 8, 2014
Financial News

Curetis financial update

...$34.3 million). New investors Qiagen and LSP Health Econimics Fund joined existing investors HBM Partners; Aeris Capital...
BioCentury | Sep 13, 2014
Financial News

Affimed raises $56M in IPO

...million ($15.4 million) from existing investors in a series E round last week. Investors included Aeris Capital...
BioCentury | Sep 3, 2014
Financial News

Affimed sets IPO terms, raises series E

...Capital; and Trout Capital are underwriters. The E round came from Affimed's existing investors, including Aeris Capital...
BioCentury | Jun 16, 2014
Finance

Legal tracks

...and a director of RNAi company Solstice Biologics LLC . Solstice's investors include venBio and Aeris Capital. ...
BioCentury | Oct 7, 2013
Finance

Deciphering GenomeDx

...Fund (GHIF) and another new investor that was not disclosed. Existing investors Baird Venture Partners, Aeris Capital...
BioCentury | Oct 7, 2013
Financial News

GenomeDx Biosciences completes venture financing

...Type: Venture financing Raised: Not disclosed Investors: Merck Global Health Innovation Fund; Baird Venture Partners; Aeris Capital...
BioCentury | Oct 1, 2013
Financial News

GenomeDx closes series B round

...Merck Global Health Innovation Fund and a new undisclosed investor. Existing investors Baird Venture Partners; Aeris Capital...
BioCentury | Jul 22, 2013
Company News

Affimed board of directors update

...Adi Hoess, CEO of Affimed, as a director of Amphivena; and Frank Muehlenbeck, partner at Aeris Capital...
BioCentury | Jul 22, 2013
Financial News

Affimed completes venture financing

...Cancer, Inflammation, Antibodies Date completed: 7/15/13 Type: Venture financing Raised: $14 million Investors: MPM Capital; Aeris Capital...
Items per page:
1 - 10 of 37